Compounded by Qualified Pharmacists Our licensed pharmacists prepare every peptide prescription in a sterile compounding laboratory
Clinical implication: clinicians should treat vaginal symptoms in patients taking semaglutide as real and addressable , but approach causality cautiously: prioritise common diagnoses (genitourinary syndrome of menopause, infections, dermatologic vulvar disease, STIs, irritant/contact dermatitis, pelvic floor disorders), identify important confounders (notably SGLT2 inhibitors, antibiotics, hormonal therapies), manage symptoms and underlying conditions, and report suspected adverse reactions when there is a reasonable temporal relationship and alternative causes are less likely
To maximize effectiveness, you cant eat like you did before
BPC-157 (Body Protection Compound 157) is not a licensed medicine or drug and has not been approved by the MHRA, FDA, or any regulatory authority for use in humans or animals
CJC 1295/Ipamorelin is a combination of two peptides that work together to stimulate the release of growth hormone in the body
Clinical Chemistry and Laboratory Medicine 41 (11): 14781488
